GlycoMimetics
Why Robinhood?
You can watch GlycoMimetics and buy or sell other stocks, ETFs, and their options commission-free!About GLYC
Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.
GLYC Key Statistics
Stock Snapshot
The current GlycoMimetics(GLYC) stock price is $13.04, with a market capitalization of 359.54M. The stock trades at a price-to-earnings (P/E) ratio of -1.31.
GlycoMimetics(GLYC) stock opened on 2026-07-26 at —. The price climbed to — and dipped to —.
The GlycoMimetics(GLYC)'s current trading volume is 0, compared to an average daily volume of 554.06K.
During the past year, GlycoMimetics(GLYC) stock moved between $8.72 at its lowest and $27.41 at its peak.
During the past year, GlycoMimetics(GLYC) stock moved between $8.72 at its lowest and $27.41 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.